FDA Approves 1st Long-Acting HIV Drug Combo, Monthly Shots
U.S. regulators have approved the first long-acting drug combo for HIV, monthly shots that can replace the daily pills now used to control infection...
Oxford Scientists In The UK, Who Developed Covid Vaccine, Launch HIV Jab Clinical Trial
The University of Oxford has launched a Phase I trial of a novel mosaic vaccine targeting a ‘broad range’ of HIV variants.
The HIV-CORE 0052...
First Patients Receive Clinical Trial Of HIV Vaccine Using Moderna’s mRNA Technology
The first participants have been vaccinated in a Phase 1 clinical trial of an experimental HIV vaccine that utilizes Moderna's mRNA technology, the company...
FDA Approves Cabenuva, The First Monthly HIV Drug Treatment
A new monthly HIV treatment — the first of its kind — could benefit hundreds of thousands of people currently taking daily pills to...